Cyclana Bio raises £5m pre-seed led by NfX and Eka VC to advance drug discovery for endometriosis through tissue-level therapeutics

Cyclana Bio develops tissue level disease models to discover new treatments for endometriosis, using whole tissue analysis rather than traditional cell focused drug discovery methods.